Clinical Trials Directory

Trials / Completed

CompletedNCT00673309

Assessment of Mechanisms of Improved Wound Healing

Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned Patients

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
644 (actual)
Sponsor
The University of Texas Medical Branch, Galveston · Academic / Other
Sex
All
Age
90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find ways to improve wound healing and decrease the negative effects of trauma from burn injury.

Detailed description

This study involves research and the investigators hope to learn the following: how or what effect one or more anabolic ("tissue building") agents have on muscle metabolism, wound healing, and immune function after severe burn. The agents include the following: growth hormone, insulin-like growth factor-1 in combination with its binding proteins, insulin, Beta-adrenergic blockers, Alpha Adrenergic Agonist, anabolic steroids such as testosterone, Oxandrolone and nandrolone, ketoconazole and its derivatives, dehydroepiandrosterone, fenofibrate, diet or the application of skin substitute.

Conditions

Interventions

TypeNameDescription
PROCEDUREStable Isotope Infusion studyStable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues. Includes collection of blood and tissues (muscle)
DRUGInsulin High DoseInsulin IV administered continuously throughout hospitalization until wounds are 95% healed.
DRUGoxandroloneOxandrolone given daily throughout hospitalization until 95% wound healing.
DRUGPropranololPropranolol to be given daily throughout hospitalization until 95% wound healing.
DRUGGrowth HormoneRecombinant Human Growth hormone to be administered daily until 95% wound healing.
DRUGInsulin Low DoseInsulin administered IV until 95% wound healing
DRUGIGF-1/IGFBP-3Insulin Like Growth Factor-1/Insulin like Growth Factor Binding Protein 3 administered until 95% wound healing
DRUGItraconazoleItraconazole administered until 95% wound healing
DRUGGrowth Hormone and PropranololGrowth Hormone and Propranolol given until 95% wound healing
DRUGOxandrolone and PropranololOxandrolone and Propranolol
DRUGPlacebo or ControlAdministration of Placebo or Control until 95% wound healing

Timeline

Start date
2000-07-01
Primary completion
2011-04-01
Completion
2013-04-01
First posted
2008-05-07
Last updated
2023-07-03
Results posted
2019-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00673309. Inclusion in this directory is not an endorsement.

Assessment of Mechanisms of Improved Wound Healing (NCT00673309) · Clinical Trials Directory